Amount Raised
$87 Million
Round Type
Series C
Foster CityBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharmaDescription
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today announced the closing of an $87 million Series C financing. The financing round was led by Deerfield Management Company alongside a strategic equity investment by Eli Lilly and Company with participation from OrbiMed Advisors, Lilly Asia Ventures, Vivo Capital, Samsara Capital, Suvretta Capital Management and several other new investors. Elise Wang, Partner at Deerfield, has joined the Terns Pharmaceuticals Board of Directors.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Terns Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- ISOThrive raised $5.2M on February 5, 2021.
- Parabilis Medicines raised $23M on January 5, 2021.
- OnKure Therapeutics, Inc. raised $47M on December 21, 2020.
- Oragenics raised $21M (Series C) on February 12, 2021.
- Day One Biopharmaceuticals raised $130M (Series B) on February 10, 2021.
- Citius Pharmaceuticals, Inc. raised $20M on February 1, 2021.
Who to call at Terns Pharmaceuticals, and when
A new round usually means Terns Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Terns Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terns Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Terns Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terns Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Terns Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.